Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically for the treatment of type 2 diabetes, chronic weight management, and the reduction of cardiovascular and renal risks. To… Read more













![Chemical structure of [4-31] -Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-31-Semaglutide.png&w=3840&q=75)
![Chemical structure of [8-31]-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8-31-Semaglutide.png&w=3840&q=75)
![Chemical structure of [D-Arg]30 Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Arg30-Semaglutide.png&w=3840&q=75)
![Chemical structure of [D-Glu3]-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Glu3-Semaglutide.png&w=3840&q=75)
![Chemical structure of [Endo-Aib(2)]-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FEndo-Aib2-Semaglutide.png&w=3840&q=75)
![Chemical structure of [Glu]-17-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FGlu-17-Semaglutide.png&w=3840&q=75)
![Chemical structure of [Trp²⁵(tBu)]-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FTrptBu-Semaglutide.png&w=3840&q=75)

![Chemical structure of Anhydro-Des-[Oct-Gamma-Glu-AEEA-AEEA]-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FAnhydro-Des-Oct-Gamma-Glu-AEEA-AEEA-Semaglutide.png&w=3840&q=75)



![Chemical structure of D-[Asp]-9-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Asp-9-Semaglutide.png&w=3840&q=75)
![Chemical structure of D-[Glu]15-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Glu15-Semaglutide.png&w=3840&q=75)
![Chemical structure of D-[Phe]-6-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Phe-6-Semaglutide.png&w=3840&q=75)
![Chemical structure of D-[Ser]-11-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Ser-11-Semaglutide.png&w=3840&q=75)
![Chemical structure of D-[Ser]-8-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Ser-8-Semaglutide.png&w=3840&q=75)
![Chemical structure of D-[Val]-10-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Val-10-Semaglutide.png&w=3840&q=75)










![Chemical structure of Des-[Gly]-31-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDes-Gly-31-Semaglutide.png&w=3840&q=75)
![Chemical structure of Des-[Oct-γ-Glu-AEEA-AEEA]-Semaglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDes-Oct-Glu-AEEA-AEEA-Semaglutide.png&w=3840&q=75)







Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically for the treatment of type 2 diabetes, chronic weight management, and the reduction of cardiovascular and renal risks. To support the rigorous analytical requirements of pharmaceutical development, this category provides a comprehensive selection of reference standards, synthetic impurities, metabolites, and stable isotope labelled compounds. Laboratories utilize these specialized materials for impurity profiling, allowing for the precise identification and quantification of process-related contaminants and degradation products within drug formulations. By incorporating stable isotope labelled standards into mass spectrometry and high-performance liquid chromatography workflows, researchers ensure high accuracy during method validation and stability studies. These essential reference tools maintain the integrity of quality control protocols, helping to verify the purity, strength, and regulatory compliance of Semaglutide across every stage of the pharmaceutical lifecycle.